The NHS has recently announced that it will be offering more than 150,000 adults and children with type 1 diabetes (T1DM) in England and Wales advanced technological treatment in the form of “artificial pancreas” devices, which experts are hailing as a “gamechanger” that will “save lives and heartbreak”.
The artificial pancreas device, also called a hybrid closed loop (HCL) system, uses a hi-tech algorithm to determine the amount of insulin that should be administered and monitors blood sugar levels to maintain them at safe and appropriate levels.